Publications by authors named "Pierre Morange"

Claim this Profile
T
The Procoagulant and Fibrinolytic Balance of Extracellular Vesicles Predicts Mortality in Septic Shock Patients.
Romaric Lacroix, Coralie Judicone, Karim Harti Souab, Amandine Bonifay, Anderson Loundou, Pierre Morange

J Extracell Vesicles· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Molecular Biology in Diagnosis, Prognosis, and Therapeutic Management of -Negative Myeloproliferative Neoplasm.
Norman Abbou, Pauline Piazzola, Jean Gabert, Vincent Ernest, Robin Arcani, Pierre Morange

Cells· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two SERPINC1 variants affecting N-glycosylation of Asn224 cause severe thrombophilia not detected by functional assays.
Maria Eugenia de la Morena-Barrio, Pierre Suchon, Eva Marie Jacobsen, Nina Iversen, Antonia Miñano, Pierre Emmanuel Morange

Blood· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipoprotein(a): Pathophysiology, measurement, indication and treatment in cardiovascular disease. A consensus statement from the Nouvelle Société Francophone d'Athérosclérose (NSFA).
Vincent Durlach, Dominique Bonnefont-Rousselot, Franck Boccara, Mathilde Varret, Mathilde Di-Filippo Charcosset, Pierre E Morange

Arch Cardiovasc Dis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The EHA Research Roadmap: Blood Coagulation and Hemostatic Disorders.
Sabine Eichinger, Pierre E Morange, Marco Cattaneo, Mathilde Fretigny, Antoine Rauch

Hemasphere· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The aminosterol Claramine inhibits β-secretase 1-mediated insulin receptor cleavage.
Bénédicte Gaborit, Roland Govers, Alexandre Altié, Jean Michel Brunel, Pierre Morange

J Biol Chem· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SLC44A2 deficient mice have a reduced response in stenosis but not in hypercoagulability driven venous thrombosis.
Julia Tilburg, Daniëlle M Coenen, Gaia Zirka, Sophie Dólleman, Annemarie M van Oeveren-Rietdijk, Pierre E Morange

J Thromb Haemost· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common Risk Factors Add to Inherited Thrombophilia to Predict Venous Thromboembolism Risk in Families.
Pierre Suchon, Noemie Resseguier, Manal Ibrahim, Alexia Robin, Geoffroy Venton, Pierre E Morange

TH Open· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial strides for invent-VTE: Towards global collaboration to accelerate clinical research in venous thromboembolism.
Marc Rodger, Nicole Langlois, Saskia Middeldorp, Susan Kahn, Per Morten Sandset, Pierre Morange

Thromb Res· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit of Switching Dual Antiplatelet Therapy After Acute Coronary Syndrome According to On-Treatment Platelet Reactivity: The TOPIC-VASP Pre-Specified Analysis of the TOPIC Randomized Study.
Pierre Deharo, Jacques Quilici, Laurence Camoin-Jau, Thomas W Johnson, Clémence Bassez, Pierre Emmanuel Morange

JACC Cardiovasc Interv· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study.
Thomas Cuisset, Pierre Deharo, Jacques Quilici, Thomas W Johnson, Stéphanie Deffarges, Pierre Emmanuel Morange

Eur Heart J· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrothrombocytopenia and dense granule deficiency associated with FLI1 variants: ultrastructural and pathogenic features.
Paul Saultier, Léa Vidal, Matthias Canault, Denis Bernot, Céline Falaise, Pierre Emmanuel Morange

Haematologica· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline variants in ETV6 underlie reduced platelet formation, platelet dysfunction and increased levels of circulating CD34+ progenitors.
Marjorie Poggi, Matthias Canault, Marie Favier, Ernest Turro, Paul Saultier, Pierre Emmanuel Morange

Haematologica· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is platelet inhibition correlated with time from last intake on P2Y12 blockers after an acute coronary syndrome? A pilot study.
Pierre Deharo, Jacques Quilici, Guillaume Bonnet, Charlotte Grosdidier, Pierre Morange

Platelets· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic determined low response to thienopyridines is associated with higher systemic inflammation in smokers.
Payman Shahabi, Thomas Cuisset, Maria G Stathopoulou, Pierre Emmanuel Morange, Charlotte Grosdidier

Pharmacogenomics· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Theme 2: Epidemiology, Biomarkers, and Imaging of Venous Thromboembolism (and postthrombotic syndrome).
Henri M H Spronk, Suzanne Cannegieter, Pierre Morange, Tilman Hackeng, Menno Huisman

Thromb Res· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic kidney disease has a significant impact on platelet inhibition of new P2Y12 inhibitors.
Pierre Deharo, Mathieu Pankert, Jacques Quilici, Guillaume Bonnet, Clemence Bassez, Pierre Morange

Int J Cardiol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Antiphospholipids antibodies and hemodialysis: a frequent association linked to arteriovenous fistula thrombosis].
Stanislas Bataille, Stéphane Burtey, Alexandre Decourt, Corinne Frère, Agathe Henneuse, Pierre Morange

Nephrol Ther· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of switching 'low responders' to prasugrel to ticagrelor after acute coronary syndrome.
Clémence Bassez, Pierre Deharo, Mathieu Pankert, Guillaume Bonnet, Jacques Quilici, Pierre Morange

Int J Cardiol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body mass index has no impact on platelet inhibition induced by ticagrelor after acute coronary syndrome, conversely to prasugrel.
Pierre Deharo, Mathieu Pankert, Guillaume Bonnet, Jacques Quilici, Clemence Bassez, Pierre Morange

Int J Cardiol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human CalDAG-GEFI gene (RASGRP2) mutation affects platelet function and causes severe bleeding.
Matthias Canault, Dorsaf Ghalloussi, Charlotte Grosdidier, Marie Guinier, Claire Perret, Pierre E Morange

J Exp Med· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fixed-dose aspirin-clopidogrel combination enhances compliance to aspirin after acute coronary syndrome.
Pierre Deharo, Jacques Quilici, Guillaume Bonnet, Mathieu Pankert, Valentine Verdier, Pierre Morange

Int J Cardiol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of obesity and the metabolic syndrome on response to clopidogrel or prasugrel and bleeding risk in patients treated after coronary stenting.
Mathieu Pankert, Jacques Quilici, Anderson Diendonné Loundou, Valentine Verdier, Marc Lambert, Pierre Emmanuel Morange

Am J Cardiol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prasugrel versus ticagrelor in acute coronary syndrome: a randomized comparison.
Pierre Deharo, Clemence Bassez, Guillaume Bonnet, Mathieu Pankert, Jacques Quilici, Pierre Morange

Int J Cardiol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical implications of very low on-treatment platelet reactivity in patients treated with thienopyridine: the POBA study (predictor of bleedings with antiplatelet drugs).
Thomas Cuisset, Charlotte Grosdidier, Anderson Diendonné Loundou, Jacques Quilici, Marie Loosveld, Pierre Emmanuel Morange

JACC Cardiovasc Interv· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis